Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system
Contraception(2020)
摘要
Objective
To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS).
Study Design
We assessed pregnancy rates through 72 months in women aged 16–35 years at enrollment and safety in all participants (aged 16–45 years, n = 1751) in an ongoing 10-year phase-3 trial.
Results
Over six years, nine pregnancies occurred (none in year 6) for a life-table pregnancy rate of 0.87 (95% CI 0.44–1.70). Adverse event rates remain low through 6 or more years of use. Two expulsions occurred in year 6.
Conclusion
This levonorgestrel 52 mg IUS is a highly effective and safe contraceptive over 6 years of use.
Implications
The levonorgestrel 52 mg IUS shows high 6-year contraceptive efficacy and a low rate of adverse events through 6 or more years of use.
更多查看译文
关键词
Levonorgestrel,Intrauterine system,Liletta,Efficacy,Safety
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要